This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2003 Mar 11;60(5):883-4.

doi: 10.1212/01.wnl.0000049936.85487.7a.

Minocycline for Huntington's disease: an open label study

Raphael M Bonelli¹, Clemens Heuberger, Franz Reisecker

Affiliations

PMID: 12629257
DOI: 10.1212/01.wnl.0000049936.85487.7a

Clinical Trial

Minocycline for Huntington's disease: an open label study

Raphael M Bonelli et al. Neurology. 2003.

. 2003 Mar 11;60(5):883-4.

doi: 10.1212/01.wnl.0000049936.85487.7a.

Authors

Raphael M Bonelli¹, Clemens Heuberger, Franz Reisecker

Affiliation

¹ Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria. rm.bonelli@nextra.at

PMID: 12629257
DOI: 10.1212/01.wnl.0000049936.85487.7a

No abstract available

PubMed Disclaimer

Similar articles

Minocycline safety and tolerability in Huntington disease.
Huntington Study Group. Huntington Study Group. Neurology. 2004 Aug 10;63(3):547-9. doi: 10.1212/01.wnl.0000133403.30559.ff. Neurology. 2004. PMID: 15304592 Clinical Trial.
Maintained improvement with minocycline of a patient with advanced Huntington's disease.
Denovan-Wright EM, Devarajan S, Dursun SM, Robertson HA. Denovan-Wright EM, et al. J Psychopharmacol. 2002 Dec;16(4):393-4. doi: 10.1177/026988110201600417. J Psychopharmacol. 2002. PMID: 12503842
A futility study of minocycline in Huntington's disease.
Huntington Study Group DOMINO Investigators. Huntington Study Group DOMINO Investigators. Mov Disord. 2010 Oct 15;25(13):2219-24. doi: 10.1002/mds.23236. Mov Disord. 2010. PMID: 20721920 Free PMC article. Clinical Trial.
Minocycline and other tetracycline derivatives: a neuroprotective strategy in Parkinson's disease and Huntington's disease.
Thomas M, Le WD, Jankovic J. Thomas M, et al. Clin Neuropharmacol. 2003 Jan-Feb;26(1):18-23. doi: 10.1097/00002826-200301000-00005. Clin Neuropharmacol. 2003. PMID: 12567160 Review. No abstract available.
Clinical potential of minocycline for neurodegenerative disorders.
Blum D, Chtarto A, Tenenbaum L, Brotchi J, Levivier M. Blum D, et al. Neurobiol Dis. 2004 Dec;17(3):359-66. doi: 10.1016/j.nbd.2004.07.012. Neurobiol Dis. 2004. PMID: 15571972 Review.

See all similar articles

Cited by

Update on Huntington's disease.
Berman SB, Greenamyre JT. Berman SB, et al. Curr Neurol Neurosci Rep. 2006 Jul;6(4):281-6. doi: 10.1007/s11910-006-0019-6. Curr Neurol Neurosci Rep. 2006. PMID: 16822347 Review.
Lack of minocycline efficiency in genetic models of Huntington's disease.
Mievis S, Levivier M, Communi D, Vassart G, Brotchi J, Ledent C, Blum D. Mievis S, et al. Neuromolecular Med. 2007;9(1):47-54. doi: 10.1385/nmm:9:1:47. Neuromolecular Med. 2007. PMID: 17114824
Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance.
Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. Frenzel T, et al. Cerebrovasc Dis. 2008;25(1-2):157-63. doi: 10.1159/000113733. Epub 2008 Jan 23. Cerebrovasc Dis. 2008. PMID: 18212521 Free PMC article. Clinical Trial.
Prospects for minocycline neuroprotection.
Plane JM, Shen Y, Pleasure DE, Deng W. Plane JM, et al. Arch Neurol. 2010 Dec;67(12):1442-8. doi: 10.1001/archneurol.2010.191. Epub 2010 Aug 9. Arch Neurol. 2010. PMID: 20697034 Free PMC article. Review.
Drug repositioning for Alzheimer's disease.
Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, Hagan JJ, Holmes C, Jones E, Katona C, Kearns I, Kehoe P, Mudher A, Passmore A, Shepherd N, Walsh F, Ballard C. Corbett A, et al. Nat Rev Drug Discov. 2012 Nov;11(11):833-46. doi: 10.1038/nrd3869. Nat Rev Drug Discov. 2012. PMID: 23123941 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information